Incyte (INCY -2.7%) slips after Morgan Stanley says current consensus estimates don't reflect...

|About: Incyte Corporation (INCY)|By:, SA News Editor

Incyte (INCY -2.7%) slips after Morgan Stanley says current consensus estimates don't reflect myelofibrosis competition, which could impact Incyte's Jakafi sales.